Zishu Wang

Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial

Shukui Qin, Feng Bi, Shanzhi Gu et al. · Journal of Clinical Oncology · 2021 · 383 citations · Full text

Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Shukui Qin, Li Qiu, Shanzhi Gu et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 243 citations

Hepatology, Medicine, Pathology +6

MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells

Yang Liu, Yumei Li, Rui Wang et al. · Journal of Experimental & Clinical Cancer Research · 2016 · 89 citations · Full text

Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer

Zishu Wang, Jin Wang, Yan Yang et al. · Journal of Experimental & Clinical Cancer Research · 2013 · 65 citations · Full text

Schisantherin A induces cell apoptosis through ROS/JNK signaling pathway in human gastric cancer cells

Zishu Wang, Kaikai Yu, Yudong Hu et al. · Biochemical Pharmacology · 2019 · 65 citations

Signaling Pathway, Chemoprevention Strategy, Pathology +6